Monitoring lidocaine single-crystal dissolution by ultraviolet imaging

Journal of Pharmaceutical Sciences

Volumn 100, Issue 8, 2011, Pages 3405-3410

  Østergaard, Jesper ^a   Ye, Fengbin ^a   Rantanen, Jukka ^a   Yaghmur, Anan ^a   Larsen, Susan Weng ^a   Larsen, Claus ^a   Jensen, Henrik ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Crystals; Dissolution; Dissolution rate; Imaging methods; Natural convection; UV imaging; UV Vis spectroscopy

Indexed keywords

LIDOCAINE; PHOSPHATE BUFFERED SALINE;

ARTICLE; CRYSTAL STRUCTURE; DRUG DETERMINATION; DRUG SOLUBILITY; DRUG STRUCTURE; ULTRAVIOLET RADIATION;

EID: 79958812828     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22532     Document Type: Article

References (27)

1. Amidon GL, Lennernäs H, Shah VP, Crison JR. 1995. A theoretical basis for a biopharmaceutical drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 12:413-419.
2. Mudie DM, Amidon GL, Amidon GE. 2010. Physiological parameters for oral delivery and in vitro testing. Mol Pharm 7:1388-1405.
3. Dokoumetzidis A, Macheras P. 2006. A century of dissolution research: From Noyes and Whitney to the biopharmaceutics classification system. Int J Pharm 321:1-11.
4. McAllister M. 2010. Dynamic dissolution: A step closer to predictive dissolution testing? Mol Pharm 7:1374-1387.
5. Morissette SL, Soukasene S, Levinson D, Cima MJ, Almarsson Ö. 2003. Elucidation of crystal form diversity of the HIV protease inhibitor ritonavir by high-throughput crystallization. Proc Natl Acad Sci U S A 100:2180-2184.
6. Avdeef A, Tsinman O. 2008. Miniaturized rotating disk intrinsic dissolution rate measurement: Effects of buffer capacity in comparisons to traditional Wood's apparatus. Pharm Res 25:2613-2627.
7. Tsinman K, Avdeef A, Tsinman O, Voloboy D. 2009. Powder dissolution method for estimating rotating disk intrinsic dissolution rates of low solubility. Pharm Res 26:2093-2100.
8. Persson AM, Baumann K, Sundelöf L-A, Lindberg W, Sokolowski A, Pettersson C. 2008. Design and characterization of a new miniaturized rotating disk equipment for in vitro dissolution rate studies. J Pharm Sci 97:3344-3355.
9. Richardson JC, Bowtell RW, Mäder K, Melia CD. 2005. Pharmaceutical applications of magnetic resonance imaging (MRI). Adv Drug Del Rev 57:1191-1209.
10. Metz H, Mäder K. 2008. Benchtop-NMR and MRI-A new analytical tool in drug delivery research. Int J Pharm 364:170-175.
11. Young PM, Nguyen K, Jones AS, Traini D. 2008. Microstructural analysis of porous composite materials: Dynamic imaging of drug dissolution and diffusion through porous matrices. AAPS J 10:560-564.
12. Kazarin SG, Van Der Weerd J. 2008. Simultaneous FTIR spectroscopic imaging and visible photography to monitor tablet dissolution and drug release. Pharm Res 25:853-860.
13. Kazarin SG, Chan KLA. 2003. "Chemical photography" of drug release. Macromolecules 36:9866-9872.
14. Van Der Weerd J, Kazarin SG. 2005. Release of poorly soluble drugs from HPMC tablets studies by FTIR imaging and flow-through dissolution tests. J Pharm Sci 94:2096-2109.
15. Nott KP. 2010. Magnetic resonance imaging of tablet dissolution. Eur J Pharm Biopharm 74:78-83.
16. Østergaard J, Meng-Lund E, Larsen SW, Larsen C, Petersson K, Lenke J, Jensen H. 2010. Real-time UV imaging of nicotine release from transdermal patch. Pharm Res 27:2614-2623.
17. Unwin PR, Macpherson JV. 1995. New strategies for probing crystal dissolution kinetics at the microscopic level. Chem Soc Rev 24:109-119.
18. Burt HM, Mitchell AG. 1979. Dissolution anisotropy in nickel sulfate a hexahydrate crystals. Int J Pharm 3:261-274.
19. Prasad KVR, Ristic RI, Sheen DB, Sherwood JN. 2002. Dissolution kinetics of paracetamol single crystals. Int J Pharm 238:29-41.
20. Raghavan SL, Ristic RI, Sheen DB, Sherwood JN. 2002. Dissolution kinetics of single crystals of α-lactose monohydrate. J Pharm Sci 91:2166-2174.
21. Rodley GA, Chan H-K, Gonda I. 1993. Dissolution studies of hexamethylamine. Int J Pharm 95:143-151.
22. D'Arcy DM, Corrigan OI, Healy AM. 2006. Evaluation of hydrodynamics in the basket dissolution apparatus using computational fluid dynamics-dissolution rate implications. Eur J Pharm Sci 27:259-267.
23. Stevens LE, Missel PJ. 2006. Impact of density gradients on flow-through dissolution in a cylindrical flow cell. Pharm Dev Technol 11:529-534.
24. D'Arcy DM, Liu B, Bradley G, Healy AM, Corrigan OI. 2010. Hydrodynamic and species transfer simulations in the USP 4 dissolution apparatus: Considerations for dissolution in a low velocity pulsing flow. Pharm Res 27:246-258.
25. Pedersen BT, Larsen SW, Østergaard J, Larsen C. 2008. In vitro assessment of lidocaine release from aqueous and oil solutions and from preformed and in situ formed aqueous and oil suspensions. Parenteral depots for intra-articular administration. Drug Deliv 15:23-30.
26. Gröningsson K, Lindgren J-E, Lundberg E, Sandberg R, Wahlén A. 1985. Lidocaine base and hydrochloride. In Analytical profiles of drug substances; Florey K, Ed. Vol XIV, Orlando: Academic Press, pp 207-243.
27. Bambagiotti-Alberti M, Bruni B, Di Vaira M, Giannellini V, Guerri A. 2007. 2-(Diethylamino)-N-(2, 6-dimethylphenyl)-acetamide, a low-temperature redetermination. Acta Cryst E63:o768-o770.